openPR Logo
Press release

Transthyretin Amyloidosis (ATTR) Market 2019 |New Business Opportunities and Investment | Most Eminent Players- Alnylam Pharmaceuticals, Pfizer, Merck, Ionis Pharmaceuticals Inc. and More

03-12-2019 03:11 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Transthyretin Amyloidosis (ATTR) Market

Transthyretin Amyloidosis (ATTR) Market

Market Scenario

The Transthyretin (TTR) amyloidosis market is expected to register a sturdy growth during the forecast period. Transthyretin (TTR) amyloidosis is a medical condition characterized by the buildup of abnormal deposits of a protein called amyloid (amyloidosis) in a body's organs and tissues. It generally affects peripheral neuropathic or autonomic neuropathy system and cardiac system. The cardiac form of Transthyretin (TTR) amyloidosis puts patients at the risk of arrhythmia, cardiomegaly, and orthostatic hypertension. The global ATTR market is likely to exhibit a robust growth during the forecast period due to the probability of rising number of ATTR therapeutic drugs launches, increasing African-American population as they are genetically susceptible to amyloidosis, increasing healthcare awareness among people, and rising average income of individuals. However, the growth of this market can be hindered by stringent regulatory policies, the high cost of ATTR drugs, incorrect diagnosis of ATTR disorders and limitations of clinical trials. Lack of knowledge about this condition and unavailability of advanced diagnostic methods in the middle-income countries are the major challenges to the market.

Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/6155

Top Market Players

Alnylam Pharmaceuticals
Pfizer
Merck
Ionis Pharmaceuticals Inc.
Corino Therapeutics Inc
Arcturus Therapeutics
Proclara Bioscience
Market Segmentation

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

The global Transthyretin (TTR) amyloidosis market is segmented on the basis of disease type, treatment, gender, and end-user. Considering the type of disease, the market is segmented into Transthyretin (TTR) familial amyloid polyneuropathy, Transthyretin (TTR) familial amyloid cardiomyopathy, and others. On the basis of treatment, the market is segmented into small molecules treatment, RNAi therapy, organ transplantation, and others. Small molecules treatment is further segmented into tafamidis and diflunisal. On gender basis, it is segmented into male and female. According to end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others.

Regional Market Summary

Americas dominates the market for Transthyretin (TTR) amyloidosis owing to the increasing prevalence of amyloidosis among adults and older population and rising geriatric population which is a major trigger factor for this disease. For instance, according to a report published by ASCO Journal in 2016 around 4,000 people developed amyloidosis each year in the United States. Thus, this rising patient pool is going to boost up the market growth during the forecast period. Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and rising use of technologically advanced medical diagnostic devices are likely to drive the market. The presence of pharmaceutical giants such as Pfizer, Merck, etc. also propels the market growth in this region.

Asia Pacific is expected to be the fastest growing market. According to a report published by the United Nations in 2015the number of older people aged 60 years or over in the world is predicted to grow by 56% between 2015 and 2030, out of which 66% of the older population would reside in the Asia Pacific region. This makes the region prone to Transthyretin (TTR) amyloidosis as chances of its prevalence increases with the increasing age. Owing to a huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability favorable insurance and reimbursement policies, the market growth will be accelerated during the forecast period. Moreover, key players such as Pfizer, Merck, etc. have been setting up their regional headquarters and manufacturing plants in countries such as Singapore, China, Japan, Korea, and Australia. Thus, the growth curve of the Transthyretin (TTR) amyloidosis market will see a positive trend of growth.

Europe is the second largest market and holds a healthy share in the global Transthyretin (TTR) amyloidosis market. The European market is expected to exhibit robust growth during the forecast period due to major driving factors such as availability of advanced treatment facilities, increasing healthcare expenditure along with growing need for better healthcare infrastructure, and government initiatives of healthcare reform. It is reported that in the U.K., around 60 new cases of Transthyretin (TTR) amyloidosis are reported annually, and the age-specific incidence rate of it is between 5.1 and 12.8 per million per year. Additionally, established medical device market and capability of inhabitants to afford diagnostics are aiding the market growth. However, the inefficacy of treatment and wrong diagnosis are hampering the market growth of this region.

The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia are the largest markets owing to the development of the healthcare industry and rising availability of specialty care centers. But the market might show a steady growth due to the genetical susceptibility of Africans for transthyretin amyloidosis and government initiatives to improve the quality of healthcare in this region.

Browse Complete 100 Pages Premium Research Report @ https://www.marketresearchfuture.com/reports/transthyretin-amyloidosis-market-6155

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transthyretin Amyloidosis (ATTR) Market 2019 |New Business Opportunities and Investment | Most Eminent Players- Alnylam Pharmaceuticals, Pfizer, Merck, Ionis Pharmaceuticals Inc. and More here

News-ID: 1649252 • Views:

More Releases from Market Research Future

US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2024 to 2032
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Futu …
The Construction Internet of Things (IoT) market is rapidly expanding, revolutionizing the construction industry by enhancing productivity, safety, and efficiency. IoT in construction involves the use of sensors, devices, and software to collect and analyze data in real-time, enabling better decision-making and optimization of construction processes. The Construction IoT Market is estimated at US$ 51.78 billion in 2032 and is forecasted to increase rapidly at a CAGR of 16.8% from 2024
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segmentation, Revenue and Industry Expansion Forecast Report
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segm …
The logistics and supply chain market is a critical backbone of global commerce, ensuring the seamless flow of goods from production to consumption. It encompasses a vast network of processes, technologies, and providers working together to deliver products to customers efficiently and cost-effectively. Logistics & Supply Chain Market was valued at USD 9.1 Billion in 2024 and is expected to reach USD 14.72 Billion by 2032, registering a CAGR of 6.20%

All 5 Releases


More Releases for TTR

SWATCH TTR TOUR CHAMPION CROWNED IN DAYS
Vermont, USA - March 16th, 2009: The time has come to crown the men’s Swatch TTR Tour Champion at the prestigious 6Star Burton US Open. After a highly charged season, Shaun White (USA) and Peetu Piiroinen (FIN) have emerged as the two Title contenders, but only one will walk away victorious after Sunday’s Slopestyle Final. However, the Halfpipe finals on Saturday will already play an important and
Kevin Pearce new Swatch TTR World Tour Champion
Stratton, VT, USA - March 21st, 2008: After a full-out season of close calls and flawless victories, US snowboarder Kevin Pearce charged through the opposition, defeating his challengers and rising to the occasion to become the new 07/08 Men’s Swatch TTR World Snowboard Tour Champion. Kevin Pearce, a Vermont native, was crowned at 04.30 pm U.S. EST at the base of Stratton Mountain in front of a mass of spectators
TTR FOUR(4)STAR BUDWEISER BUDRIDERS’ RIVERJUMP
Livigno, Italy. TTR FOUR(4)STAR event, the 2nd Edition Budweiser Budriders’ Riverjump, set the scene for Yale Cousino (USA) to display his Slopestyle skills blowing the field away to win the contest title and 700 TTR Ranking Points at Livigno, Italy, 8th -10th March, 2007. Set in one of Europe’s best Slopestyle parks, built with top Italian craftsmanship, the Mottolino Livigno snowpark consisted of one car to slide/to bonk, two rails
TTR FOUR(4)STAR BILLABONG WORLD JUNIOR PRO
Leysin, Switzerland. Unexpected stormy winds finally forced organizers of TTR FOUR(4)STAR 4th annual Billabong World Junior Pro to cancel the Slopestyle Finals at the Mont de Chaux Snowpark, Leysin, 6th-11th March, 2007, and take the semi-final results to announce the Franck April (CAN) and Marie Hucal (USA) the Billabong World Junior Champions. Bad weather affected Saturday’s original schedule so Billabong World Junior Pro organizers and riders postponed the Finals to a
INTRODUCING HOT NEW TTR FEATURES: MYSPACE, MEDIA FRIENDS, BRAND PARTNER & TTR TO …
Innsbruck, Austria. On the quest to progress, Ticket To Ride (TTR) World Snowboard Tour launches brand spanking new features on the official website www.ttrworldtour.com, including TTR Brand Partner Ranking & Media ‘Friends’ sections and TTR’s very own myspace community. Sure to shake the industry is a team manager’s dream – the Men & Women TTR Brand Partner Top 5. Composed of official Platinum and Gold TTR Brand Partners, the ranking is
TTR FIVE(5)STAR OAKLEY ARCTIC CHALLENGE
SENSATIONAL NEWS FROM TTR FIVE(5)STAR OAKLEY ARCTIC CHALLENGE AS TERJE HAAKONSEN BREAKS WORLD RECORD FOR HIGHEST AIR & KEVIN PEARCE WINS TITLE TO BECOME THE NEW TTR TOUR LEADER Oslo, Norway. The TTR FIVE(5)STAR Oakley Arctic Challenge 2007 goes down as one of the most important chapters in snowboarding history as Terje Haakonsen (NOR) sets a new World Record for the Highest Air at an incredible 9.8-metres – whilst Kevin Pearce